Gonzalo de Miquel

Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study

Paul Jones, Dave Singh, Eric Bateman et al. · European Respiratory Journal · 2012 · 184 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Characterisation and impact of reported and unreported exacerbations: results from ATTAIN

Paul Jones, Rosa Lamarca, Ferran Chuecos et al. · European Respiratory Journal · 2014 · 83 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Lung Deposition of Aclidinium Bromide from Genuair®, a Multidose Dry Powder Inhaler

Stephen P. Newman, Denise Sutton, Rosa Segarra et al. · Respiration · 2009 · 48 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Safety and Pharmacokinetics of Multiple Doses of Aclidinium Bromide, a Novel Long‐Acting Muscarinic Antagonist for the Treatment of Chronic Obstructive Pulmonary Disease, in Healthy Participants

Josep M. Jansat, Rosa Lamarca, Gonzalo de Miquel et al. · The Journal of Clinical Pharmacology · 2009 · 44 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

First‐in‐human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of abediterol (LAS100977), a novel long‐acting Β₂‐agonist

Wolfgang Timmer, Èric Massana, Eulalia Jiménez et al. · The Journal of Clinical Pharmacology · 2014 · 18 citations

Pharmacy, Pharmacokinetics, Pharmacology +14